Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nicholas Slimack

Neurological Surgery Santa Maria, CA Medical Doctor

NPI 1265743884 CMS profile 598151

300 South Stratford Avenue, Santa Maria, CA 93454

Open in the dashboard

General payments

$1,333

31 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Nicholas Slimack of Santa Maria, CA is reported in the CMS Open Payments database as having received $1,333 across 31 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 36th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $236 5
2024 General $92 2
2023 General $189 4
2022 General $131 3
2021 General $24 1
2020 General $94 4
2019 General $568 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nicholas Slimack
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Nicholas Slimack were reported at $236. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Nicholas Slimack Neurological Surgery median Middle half National median
2019 $568 $582 $138–$3,006 $163
2020 $94 $294 $76–$2,174 $114
2021 $24 $387 $105–$2,432 $132
2022 $131 $542 $139–$2,989 $149
2023 $189 $534 $145–$2,697 $160
2024 $92 $574 $155–$3,046 $164
2025 $236 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic USA, Inc. $524 9 payments
  2. Medtronic, Inc. $291 4 payments
  3. Xtant Medical Inc $114 1 payment
  4. Stryker Corporation $107 5 payments
  5. Biocomposites Inc $78 2 payments
  6. Orthofix Medical, Inc. $62 3 payments
  7. Abbott Laboratories $43 2 payments
  8. Integra LifeSciences Corporation $38 2 payments
  9. DePuy Synthes Sales Inc. $37 1 payment
  10. RTI Surgical, Inc. $24 1 payment
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,333 31 payments
Products named General payments · program years 2019–2025
  1. O-ARM-Spine $447 6 payments
  2. ZEVO ANTERIOR CERVICAL PLATE SYSTEM $100 1 payment
  3. MEDTRONIC REUSABLE INSTRUMENTS $99 1 payment
  4. Stimulan $78 2 payments
  5. MAZOR X SYSTEM $68 1 payment
  6. Physio-Stim Osteogenesis Stimulator $62 3 payments
  7. SYNTHECEL $37 1 payment
  8. ADHERUS AUTOSPRAY DURAL SEALANT $32 1 payment
  9. NEURO $32 2 payments
  10. INFINITY OCT System $30 1 payment
  11. Other $428 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

17

Median for Neurosurgery: 83

Drug cost

$212

Median for Neurosurgery: $872

Branded share of claims

100%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $212

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 45 billing codes

Paid by Medicare

$119,763

Medicare's payments for the services billed

Medicare patients

223

Average age 73

Services billed

493

104 women, 119 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 41%
Ischemic heart disease 27%
Chronic kidney disease 23%
Depression 22%
Atrial fibrillation 17%
Osteoporosis 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

31 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record